Hodgkin lymphoma (HL) is a cancer of the lymphatic system and accounts for 12% of all lymphoma cases in Malaysia. The estimated age-standardized mortality rate of HL in this country is 0.23 per 100,000, which is higher than that of Singapore and Thailand. The disease is curable in most patients (ie, the 5-year relative survival rate of patients diagnosed at stages I and II of the disease >90%), but survivors may develop late treatment-related adverse effects. This online CPD video presents the clinical features of HL, along with an overview of its staging and prognosis. It also provides general practitioners/family physicians with information on the early signs and symptoms of the disease, and highlights the importance of early referral and intervention to maximize patient outcomes.

Presenter:
Dato Dr Chiang Kian Meng
MBBS (Mal), MRCP (UK), FRCP (Lon), FRCPA (Haem) Aust
Consultant Haematologist
Sunway Medical Centre

• Lecture
• Q&A session

Who should participate:
• Doctors

NOTE :
Please watch the video before attempting the assessment questions.

Terms & Conditions: 
■ Participants must obtain a minimum score of 4/5 (80%) to be awarded 1 point. 
■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points

To play this video, you are required to have a media player such as Windows Media Player (PC), QuickTime (MAC) or another third party media player.

Sponsored by: